Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
BackgroundIsolated RBD (iRBD) is a prominent early marker of Parkinson's disease and related disorders.ObjectivesEvaluate biomarkers of inflammation and axonal damage people with iRBD for disease progression.MethodsPlasma samples from 27 video-polysomnography confirmed iRBD patients and 25 controls were analyzed for inflammatory biomarkers (CRP, IL-6, TNF-α, IFN-γ, IL-1β) and NfL using the Meso Scale Discovery platform.ResultsPeople with iRBD had elevated plasma TNF-α and IL-6 (p = 0.013 and p = 0.051). In the iRBD group, plasma NfL was associated with objective motor tests: Timed Up and Go (R2 = 0.292, p = 0.027) and 10-m walk (R2 = 0.355, p = 0.034) and plasma TNF-α was associated with the Timed Up and Go test (R2 = 0.277, p = 0.025).ConclusionsWe report evidence of peripheral inflammation in early synuclein-related disease processes, and association of plasma NfL and TNF-α with motor dysfunction in iRBD patients, suggesting possible association with increased risk of phenoconversion.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.